Expand NYSE: HIMS Hims & Hers Health Today's Change (-3.89%) $-1.21 Current Price $29.80 Key Data Points Market Cap $7.1B Day's Range $27.90 - $30.86 52wk Range $13.74 - $70.43 Volume 2.1M Avg Vol 38M Gross Margin 60.86% Hims & Hers Health (HIMS 3.89%), the consumer-focused telehealth platform, closed Tuesday at $29.76, down 4.03%. The stock declined during the regular session after Amazon (AMZN +0.63%) launched a competing GLP-1 weight-loss program, though it has still gained 39.33% in the past week.
The company is set up for success: strong partnerships, a financing deal with the government, and a stand-out chief executive.
Amazon.com Inc (NASDAQ:AMZN)'s expanding artificial intelligence ambitions received a fresh vote of confidence after Anthropic agreed to spend more than $100 billion on Amazon Web Services over the next decade, prompting analysts to highlight both the scale of demand and growing scrutiny over returns. In a note following the announcement, analysts at Jefferies said the deal, which includes plans for Anthropic to utilize up to 5 gigawatts of computing capacity, reinforces confidence in AWS's in-house chip technology, particularly its Trainium processors.
Amazon One Medical members can get Novo Nordisk's Wegovy and Eli Lilly's Foundayo GLP-1 pills in a program that integrates primary-care services with the technology company's pharmacy business.
Amazon is expanding its footprint in healthcare, unveiling a new program aimed at simplifying access to weight-loss treatments and reshaping how GLP-1 drugs are delivered to patients. The move positions the tech giant as a growing force in the obesity drug market, long dominated by pharmaceutical leaders Eli Lilly and Novo Nordisk.
Amazon announced plans to invest up to $25 billion in Anthropic. The deal will give the AI start-up access to Amazon's custom AI chips to run its Claude models.
Amazon (AMZN) and Anthropic's massive AI deal is starting to ripple outward, and it is becoming clear that the benefits will not stop with just the biggest name
Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance.
Amazon is boosting its bet on Anthropic as the AI spending wars grow.
The GLP-1 weight-loss category exploded into a multi-billion-dollar opportunity that blends medication access with ongoing patient support.